Diabetes

Exenatide, pioglitazone effective for poorly controlled T2DM

(HealthDay)—For patients with long-standing poorly controlled type 2 diabetes mellitus (T2DM) on metformin plus a sulfonylurea, combination therapy with exenatide and pioglitazone is effective and safe, according to a study ...

Diseases, Conditions, Syndromes

Sitagliptin not linked to higher fracture risk in diabetes

(HealthDay)—Patients with diabetes often have fractures, but sitagliptin is not associated with increased fracture risk, according to a study published online Sept. 8 in Diabetes, Obesity and Metabolism.

Diabetes

Roux-en-Y surgery can reverse insulin treatment in T2DM

(HealthDay)—Roux-en-Y gastric bypass surgery (RYGB) strongly predicts insulin cessation after surgery in insulin-treated type 2 diabetes (I-T2D) patients, independent of weight loss, according to a study published online ...

Diabetes

Researchers prevent type 1 diabetes in lab

In new research published in Endocrinology, Thomas Burris, Ph.D., chair of pharmacological and physiological science at Saint Louis University, reports that his team has found a way to prevent type I diabetes in an animal ...

Diabetes

Could daylight savings time be a risk to diabetics?

Soon, many will turn back the hands of time as part of the twice-annual ritual of daylight savings time. That means remembering to change the alarm clock next to the bed, which will mean an extra hour of sleep before getting ...

page 5 from 11